Trypanothione reductase
From Proteopedia
(Difference between revisions)
Line 33: | Line 33: | ||
**[[2w0h]], [[2x50]] - LiTTR + NADPH + metal ion<br /> | **[[2w0h]], [[2x50]] - LiTTR + NADPH + metal ion<br /> | ||
- | **[[2yau]] | + | **[[2yau]], [[4apn]], [[5ebk]] - LiTTR + NADPH + inhibitor<br /> |
- | + | ||
**[[4adw]] - LiTTR + NADPH + TPT<br /> | **[[4adw]] - LiTTR + NADPH + TPT<br /> | ||
- | **[[ | + | **[[2wow]] - TbTTR + NADPH + TPT + inhibitor<BR /> |
- | + | ||
**[[1typ]] – CfTTR + NADP + TPT<BR /> | **[[1typ]] – CfTTR + NADP + TPT<BR /> | ||
}} | }} |
Revision as of 21:51, 11 October 2017
|
3D structures of trypanothione reductase
Updated on 11-October-2017
References
- ↑ Rivarola HW, Paglini-Oliva PA. Trypanosoma cruzi trypanothione reductase inhibitors: phenothiazines and related compounds modify experimental Chagas' disease evolution. Curr Drug Targets Cardiovasc Haematol Disord. 2002 Jun;2(1):43-52. PMID:12769656
- ↑ Baiocco P, Poce G, Alfonso S, Cocozza M, Porretta GC, Colotti G, Biava M, Moraca F, Botta M, Yardley V, Fiorillo A, Lantella A, Malatesta F, Ilari A. Inhibition of Leishmania infantum Trypanothione Reductase by Azole-Based Compounds: a Comparative Analysis with Its Physiological Substrate by X-ray Crystallography. ChemMedChem. 2013 Jun 3. doi: 10.1002/cmdc.201300176. PMID:23733388 doi:10.1002/cmdc.201300176